Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Okmetic Oyj retains existing FY 2014 guidance


Thursday, 24 Jul 2014 01:00am EDT 

Okmetic Oyj:Says retains existing guidance, according to which net sales and operating profit in 2014 are estimated to exceed the level of year 2013.Says reported FY 2013 net sales 68.5 million euros.Says reported FY 2013 operating profit 5.0 million euros. 

Company Quote

4.76
 --
12:29pm EDT